BI-9787

N/A

Report date: 2024/08/28 14:30:00
NME

Base Information

Drug NameBI-9787
Drug Alias NameBI-9787
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKetohexokinase inhibitors
TargetsKetohexokinase
Therapy Area/IndicationsDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A